HMA mediated downregulation of MCL-15-Aza down-regulates MCL-1 in a p53-independent manner, leading to enhanced apoptosis in AML cells when combined with ABT-737 (inhibitor of BCL-2 and BCL-xL). This evidence concerns the gene BCL2L1 and acute myeloid leukemia.